Ad is loading...
MENU

ARMP Armata Pharmaceuticals Forecast, Technical & Fundamental Analysis

a developer of novel bacteriophage-based therapeutics

Industry Biotechnology
View a ticker or compare two or three
Ad is loading...
A.I. Advisor
published Earnings

ARMP is expected to report earnings to rise 93.33% to -28 cents per share on March 13

Armata Pharmaceuticals ARMP Stock Earnings Reports
Q4'24
Est.
$-0.29
Q3'24
Beat
by $0.13
Q2'24
Beat
by $0.12
Q1'24
Missed
by $0.52
Q4'23
Missed
by $0.27
The last earnings report on November 13 showed earnings per share of -15 cents, beating the estimate of -28 cents. With 15.35K shares outstanding, the current market capitalization sits at 87.20M.
A.I. Advisor
published General Information

General Information

a developer of novel bacteriophage-based therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
5005 McConnell Avenue
Phone
+1 310 665-2928
Employees
66
Web
https://www.armatapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JBAXY12.160.11
+0.91%
Julius Baer Group Ltd.
PMVP1.610.01
+0.62%
PMV Pharmaceuticals
LND4.180.03
+0.60%
BrasilAgro - Companhia Brasileira de Propriedades Agricolas
WEGZY9.470.05
+0.53%
Weg SA
DK18.65-0.44
-2.30%
Delek US Holdings

ARMP and Stocks

Correlation & Price change

A.I.dvisor tells us that ARMP and RIGL have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARMP and RIGL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARMP
1D Price
Change %
ARMP100%
-10.07%
RIGL - ARMP
26%
Poorly correlated
-12.24%
SRRK - ARMP
25%
Poorly correlated
-3.67%
ALT - ARMP
25%
Poorly correlated
-9.99%
FRES - ARMP
24%
Poorly correlated
-0.98%
RAPT - ARMP
24%
Poorly correlated
-13.67%
More